Lusofarmaco is well known to the medical community for its commitment and dedication to scientific information activity, with a “mission” to provide strong support to the activities of health promotion and therapeutic management of commonly occurring diseases.
Lusofarmaco has an extensive know-how in a number of therapeutic areas: from cardiovascular diseases to respiratory diseases, from antibiotic therapy to neuropsychiatric and gynaecology.
The cardiovascular area include drugs for the management of arterial hypertension, ischaemic heart disease, myocardial infarction, heart failure, and hypercholesterolaemia. The respiratory area has been enriched by two active substances with proven efficacy for the treatment of obstructive respiratory diseases. Lusofarmaco is historically present in the neuropsychiatric field, and can rely on a highly effective drug in the treatment of migraine, an important antipsychotic drug, and an effective antidepressant drug.
In the section of antibiotic therapy there are drugs used to treat upper and lower respiratory tract infections and genito-urinary tract infections.
As a proof of its commitment in the scientific information field, Lusofarmaco has requested and obtained the prestigious SGS certificate, issued by the world's leading certification company, which demonstrates that the products, processes, systems, and services of the Company meet national and international standards and regulations.
Click here to visualize the certificate